SHANGHAI - Global biopharmaceutical company Bristol-Myers Squibb has called a media buying pitch in China.
It is understood that several undisclosed agencies have already been shortlisted for the business. Agencies are now are waiting for a brief and pitch date.
The incumbent agency on the account is Mindshare.
The pitch is for Bristol-Myers Squibb's over the counter medicines, including its vitamins.
Earlier this month, Bristol-Meyers Squibb agreed a new collaboration with Simcere Pharmaceutical Group, a China-based company, to jointly develop a new cancer treatment.
Top news, insights and analysis every weekday
Sign up for Campaign Bulletins
.jpg&h=268&w=401&q=100&v=20170226&c=1)
Can creativity truly be compressed? Former Cheil Australia MD Mark Anderson, now at Five by Five Global, is betting big on AI with a new seven-hour sprint model to find out.
Social media platform X is reportedly in talks to raise money at its buying price valuation of $44 billion, despite user and advertiser losses since Elon Musk’s acquisition in 2022.
From banning AP correspondents to canceling subscriptions, here are a few ways the Trump administration is intentionally stressing its own relationship with mainstream journalists.
The global talent, transformation, client and media agency leader will leave in May.
.jpg&h=334&w=500&q=100&v=20170226&c=1)
.jpg&h=334&w=500&q=100&v=20170226&c=1)
.jpg&h=334&w=500&q=100&v=20170226&c=1)
.jpg&h=268&w=401&q=100&v=20170226&c=1)
.jpg&h=268&w=401&q=100&v=20170226&c=1)